Arax Advisory Partners’s Teladoc Health TDOC Stock Holding History

Arax Advisory Partners’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$663K	Buy	78,220 +43,725	+127%	+$291K	﹤0.01%	1450
2026 Q1	$188K	Buy	34,495 +8,910	+35%	+$50K	0.01%	1111
2025 Q4	$179K	Sell	25,585 -1,228	-5%	-$9.61K	0.01%	1084
2025 Q3	$207K	Buy	26,813 +26,181	+4,143%	+$204K	﹤0.01%	1253
2025 Q2	$5.5K	Buy	632 +173	+38%	+$1.25K	﹤0.01%	2215
2025 Q1	$3.65K	Buy	459 +62	+16%	+$627	﹤0.01%	1887
2024 Q4	$3.61K	Buy	397 +376	+1,790%	+$3.63K	﹤0.01%	1854
2024 Q3	$193	Hold	21	–	–	﹤0.01%	2515
2024 Q2	$206	Sell	21 -342	-94%	-$4.17K	﹤0.01%	2435
2024 Q1	$5.48K	Sell	363 -16	-4%	-$290	﹤0.01%	883
2023 Q4	$8.17K	Sell	379 -106	-22%	-$1.96K	﹤0.01%	793
2023 Q3	$9.02K	Sell	485 -21	-4%	-$490	﹤0.01%	744
2023 Q2	$12.8K	Sell	506 -42	-8%	-$1.06K	﹤0.01%	664
2023 Q1	$14.2K	Hold	548	–	–	﹤0.01%	634
2022 Q4	$13K	Sell	548 -2	-0.4%	-$54	﹤0.01%	615
2022 Q3	$14K	Hold	550	–	–	﹤0.01%	618
2022 Q2	$18K	Hold	550	–	–	﹤0.01%	575
2022 Q1	$40K	Hold	550	–	–	0.01%	483
2021 Q4	$51K	Hold	550	–	–	0.01%	455
2021 Q3	$70K	Buy	550 +15	+3%	+$2.18K	0.01%	404
2021 Q2	$89K	Buy	+535	New	+$86.7K	0.01%	359
2020 Q4	$149K	Buy	745 +222	+42%	+$45.1K	0.02%	239
2020 Q3	$115K	Buy	523 +246	+89%	+$52.1K	0.02%	251
2020 Q2	$53K	Hold	277	–	–	0.01%	358
2020 Q1	$43K	Hold	277	–	–	0.01%	372
2019 Q4	$23K	Hold	277	–	–	0.01%	407
2019 Q3	$19K	Hold	277	–	–	0.01%	415
2019 Q2	$18K	Buy	+277	New	+$16.1K	0.01%	420
2018 Q4	$14K	Hold	277	–	–	0.01%	412
2018 Q3	$24K	Buy	+277	New	+$19.7K	0.01%	384

Other funds holding TDOC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return

Arax Advisory Partners's TDOC Position: Q2 2026 in Review

Arax Advisory Partners increased its Teladoc Health (TDOC) stake by 127% in Q2 2026, buying an estimated $291K and bringing the position to 78,220 shares worth $663K. The position accounts for ﹤0.01% of the portfolio, ranked #1450.

Arax Advisory Partners first reported a position in TDOC in Q3 2018 and has held it in 30 quarters since. 347 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

Arax Advisory Partners held 78,220 shares of Teladoc Health worth $663K as of Q2 2026.
Arax Advisory Partners bought 43,725 Teladoc Health shares in Q2 2026, an estimated $291K.
Teladoc Health made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #1450 holding.
Arax Advisory Partners first reported a position in Teladoc Health in Q3 2018 and has held it in 30 quarters since.
347 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.